Similar articles

• [Acid-related diseases. What is the current rescue treatment of choice for Helicobacter pylori: quadruple therapy (proton pump inhibitor, bismuth, tetracycline and metronidazole) or triple therapy with proton pump inhibitor, amoxicillin and levofloxacin?].

  Calvet X. Calvet X. Gastroenterol Hepatol. 2008 Jun-Jul;31(6):400-1. doi: 10.1157/13123612. Gastroenterol Hepatol. 2008. PMID: 18570821 Spanish. No abstract available.
• Multiple-antibiotic-resistant Helicobacter pylori infection eradicated with a tailor-made quadruple therapy.

  Nakajima S, Inoue H, Inoue T, Maruoka Y. Nakajima S, et al. J Gastroenterol Hepatol. 2012 Apr;27 Suppl 3:108-11. doi: 10.1111/j.1440-1746.2012.07069.x. J Gastroenterol Hepatol. 2012. PMID: 22486882
• Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.

  Fennerty MB. Fennerty MB. Am J Gastroenterol. 1998 Jan;93(1):2-3. doi: 10.1111/j.1572-0241.1998.002_c.x. Am J Gastroenterol. 1998. PMID: 9448162 Clinical Trial. No abstract available.
• [Treatment of Helicobacter pylori infections].

  Calvet Calvo X. Calvet Calvo X. Gastroenterol Hepatol. 1998 Apr;21(4):203-6. Gastroenterol Hepatol. 1998. PMID: 9633184 Review. Spanish. No abstract available.
• [Anti-Helicobacter pylori quadruple therapy].

  Fukuda Y, Sakagami T. Fukuda Y, et al. Nihon Rinsho. 2005 Nov;63 Suppl 11:442-51. Nihon Rinsho. 2005. PMID: 16363576 Review. Japanese. No abstract available.